Clinical Trial Update: FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This trial update describes an ongoing Phase 2 study evaluating a triplet therapy of FTD-TPI (trifluridine/tipiracil), bevacizumab, and radioembolization with 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FTD-TPI (trifluridine/tipiracil) (trifluridine/tipiracil)

Snippet

Sponsor: UMC Utrecht | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING